End organ fibrosis accounts for up to 45% of deaths in developed countries. In particular, lung fibrosis is a devastating disease with poor prognosis. Despite development of two new drugs, their efficacy is still limited, highlighting the need to better understand the pathobiology that accounts for fibrotic disease progression in the presence and absence of acute exacerbation or infectious drivers.
Showing 2 ideas for tag "exacerbation"
19 net votes
30 up votes
11 down votes
What triggers decompensation of cellular and molecular pathways during exacerbations of chronic lung diseases?
13 net votes
23 up votes
10 down votes